209 related articles for article (PubMed ID: 27012913)
1. Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice.
Cibulski SP; Silveira F; Mourglia-Ettlin G; Teixeira TF; dos Santos HF; Yendo AC; de Costa F; Fett-Neto AG; Gosmann G; Roehe PM
Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():1-8. PubMed ID: 27012913
[TBL] [Abstract][Full Text] [Related]
2. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
3. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
[TBL] [Abstract][Full Text] [Related]
4. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
[TBL] [Abstract][Full Text] [Related]
5. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
6. Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.
de Costa F; Yendo AC; Cibulski SP; Fleck JD; Roehe PM; Spilki FR; Gosmann G; Fett-Neto AG
PLoS One; 2014; 9(8):e105374. PubMed ID: 25148077
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.
Fleck JD; Kauffmann C; Spilki F; Lencina CL; Roehe PM; Gosmann G
Vaccine; 2006 Nov; 24(49-50):7129-34. PubMed ID: 16887242
[TBL] [Abstract][Full Text] [Related]
8. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
9. Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From
Cibulski S; Varela APM; Teixeira TF; Cancela MP; Sesterheim P; Souza DO; Roehe PM; Silveira F
Front Immunol; 2021; 12():632714. PubMed ID: 33746970
[TBL] [Abstract][Full Text] [Related]
10. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
[TBL] [Abstract][Full Text] [Related]
11. IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice.
Cibulski S; Teixeira TF; Varela APM; de Lima MF; Casanova G; Nascimento YM; Fechine Tavares J; da Silva MS; Sesterheim P; Souza DO; Roehe PM; Silveira F
Vaccine; 2021 Jan; 39(3):571-579. PubMed ID: 33339669
[TBL] [Abstract][Full Text] [Related]
12. Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle.
Sadat SMA; Snider M; Garg R; Brownlie R; van Drunen Littel-van den Hurk S
Vaccine; 2017 Jun; 35(27):3466-3473. PubMed ID: 28527686
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus.
Cai D; Song Q; Duan C; Wang S; Wang J; Zhu Y
Vaccine; 2018 Sep; 36(37):5591-5599. PubMed ID: 30077483
[TBL] [Abstract][Full Text] [Related]
14. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
Platt R; Coutu C; Meinert T; Roth JA
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
[TBL] [Abstract][Full Text] [Related]
15. The induction of a cell-mediated immune response to bovine viral diarrhea virus with an adjuvanted inactivated vaccine.
Stevens ET; Zimmerman AD; Butterbaugh RE; Barling K; Scholz D; Rhoades J; Chase CC
Vet Ther; 2009; 10(4):E1-8. PubMed ID: 20425730
[TBL] [Abstract][Full Text] [Related]
16. Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses.
Cibulski SP; Rivera-Patron M; Mourglia-Ettlin G; Casaravilla C; Yendo ACA; Fett-Neto AG; Chabalgoity JA; Moreno M; Roehe PM; Silveira F
Sci Rep; 2018 Sep; 8(1):13582. PubMed ID: 30206376
[TBL] [Abstract][Full Text] [Related]
17.
Silveira F; Rivera-Patron M; Deshpande N; Sienra S; Checa J; Moreno M; Chabalgoity JA; Cibulski SP; Baz M
Front Immunol; 2023; 14():1163858. PubMed ID: 37197659
[TBL] [Abstract][Full Text] [Related]
18. Determination of new immunoadjuvant saponin named QB-90, and analysis of its organ-specific distribution in Quillaja brasiliensis by HPLC.
Fleck JD; de Costa F; Yendo AC; Segalin J; Dalla Costa TC; Fett-Neto AG; Gosmann G
Nat Prod Res; 2013; 27(10):907-10. PubMed ID: 22404569
[TBL] [Abstract][Full Text] [Related]
19. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
[TBL] [Abstract][Full Text] [Related]
20. Foamy matters: an update on
Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
